Alejandro Fernandez-Rojas

Valdivia, LR 5090000, Chile

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 19 publications

Novel Type IIS-Based Library Assembly Technique for Developing Nanobodies Targeting IPNv VP2 Protein.

Novel Type IIS-Based Library Assembly Technique for Developing Nanobodies Targeting IPNv VP2 Protein.

Journal: International journal of molecular sciences

Published: August 04, 2025

A nanobody-based therapeutic targeting Nipah virus limits viral escape.

A nanobody-based therapeutic targeting Nipah virus limits viral escape.

Journal: Nature structural & molecular biology

Published: June 10, 2024

Sumoylation in astrocytes induces changes in the proteome of the derived small extracellular vesicles which change protein synthesis and dendrite morphology in target neurons.

Sumoylation in astrocytes induces changes in the proteome of the derived small extracellular vesicles which change protein synthesis and dendrite morphology in target neurons.

Journal: Brain research

Published: August 25, 2023

Indomethacin Induces Spermidine/Spermine-N1-Acetyltransferase-1 via the Nucleolin-CDK1 Axis and Synergizes with the Polyamine Oxidase Inhibitor Methoctramine in Lung Cancer Cells.

Indomethacin Induces Spermidine/Spermine-N1-Acetyltransferase-1 via the Nucleolin-CDK1 Axis and Synergizes with the Polyamine Oxidase Inhibitor Methoctramine in Lung Cancer Cells.

Journal: Biomolecules

Published: July 04, 2023

Senolytic therapy alleviates physiological human brain aging and COVID-19 neuropathology.

Senolytic therapy alleviates physiological human brain aging and COVID-19 neuropathology.

Journal: Nature aging

Published: March 09, 2023

A nanobody recognizes a unique conserved epitope and potently neutralizes SARS-CoV-2 omicron variants.

A nanobody recognizes a unique conserved epitope and potently neutralizes SARS-CoV-2 omicron variants.

Journal: iScience

Published: February 09, 2023

Assessing Convalescent Plasma Efficacy in Moderate COVID-19 Hospitalizations: A Bicentric Retrospective Study

Assessing Convalescent Plasma Efficacy in Moderate COVID-19 Hospitalizations: A Bicentric Retrospective Study

Journal: Revista medica de Chile

Published: September 07, 2022

Development and evaluation of an 18F-labeled nanobody to target SARS-CoV-2's spike protein.

Development and evaluation of an 18F-labeled nanobody to target SARS-CoV-2's spike protein.

Journal: Frontiers in nuclear medicine

Published: August 31, 2022

SARS-CoV-2 drives NLRP3 inflammasome activation in human microglia through spike protein.

SARS-CoV-2 drives NLRP3 inflammasome activation in human microglia through spike protein.

Journal: Molecular psychiatry

Published: January 24, 2022

Negative Modulation of Macroautophagy by Stabilized HERPUD1 is Counteracted by an Increased ER-Lysosomal Network With Impact in Drug-Induced Stress Cell Survival.

Negative Modulation of Macroautophagy by Stabilized HERPUD1 is Counteracted by an Increased ER-Lysosomal Network With Impact in Drug-Induced Stress Cell Survival.

Journal: Frontiers in cell and developmental biology

Published: July 18, 2021

Lack of Parkinsonian Pathology and Neurodegeneration in Mice After Long-Term Injections of a Proteasome Inhibitor in Olfactory Bulb and Amygdala.

Lack of Parkinsonian Pathology and Neurodegeneration in Mice After Long-Term Injections of a Proteasome Inhibitor in Olfactory Bulb and Amygdala.

Journal: Frontiers in aging neuroscience

Published: April 22, 2021

Potent neutralization of clinical isolates of SARS-CoV-2 D614 and G614 variants by a monomeric, sub-nanomolar affinity nanobody.

Potent neutralization of clinical isolates of SARS-CoV-2 D614 and G614 variants by a monomeric, sub-nanomolar affinity nanobody.

Journal: Scientific reports

Published: October 19, 2020

Showing 1-12 of 19

Last Updated: 09/26/2026